Characterization of Two Potential Immunotherapeutics in Tumor Infiltrating Lymphocytes (TILs) Using Flow Cytometry and Meso Scale Discovery

Back to the list Next article Previous article

June 9, 2018

Karen K. Yam¹, Stephen Parker², Michael Agrez², Christopher Warburton¹, Adriana Alcantara¹, Vicky Sgouroudis¹, and Jean-Francois Poulin¹. ¹Caprion Biosciences Inc., Montreal, Quebec, Canada. ²Inter-K Peptide Therapeutics, New South Wales, Australia

Characterization of Two Potential Immunotherapeutics in Tumor Infiltrating Lymphocytes (TILs) Using Flow Cytometry and Meso Scale Discovery, ASCO 2018